2026 Q2 Portfolio Activity
In 2026 Q2, Tri Locum Partners LP maintained a portfolio of 22 distinct positions. The most significant new addition was ASCENDIS PHARMA A/S, now representing 8.49% of the total fund value. They heavily accumulated shares in AXSOME THERAPEUTICS INC., increasing the position by 253.1%. Conversely, Tri Locum Partners LP completely exited their position in THERMO FISHER SCIENTIFIC INC.
Position History
hover any row below to update
Loading…
Total Positions
22
Quarter
2026 Q2
Top Holding
JNJ (13.3%)
Top 10 Concentration
80.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-22 of 22
Tri Locum Partners LP Full Holdings List — 2026 Q2
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
JNJ
JOHNSON & JOHNS...
|
Healthcare | 13.27% | 14.22% |
#1
Prev: #1
|
6.5 |
—
|
10,442 | 2.5% |
P
S
|
424,945 | $107,923,282 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
VRTX
VERTEX PHARMACE...
|
Healthcare | 12.33% | 8.10% |
#2
3
Prev: #5
|
8.5 |
—
|
72,477 | 56.0% |
P
S
|
201,791 | $100,235,643 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
LLY
ELI LILLY & CO
|
Healthcare | 11.29% | 7.98% |
#3
3
Prev: #6
|
7.5 |
—
|
14,737 | 23.8% |
P
S
|
76,532 | $91,794,777 | 2020 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
N/A
ASCENDIS PHARMA...
|
|
Unknown | 8.49% | — |
#4
Prev: #—
|
7.4 |
—
|
258,740 | — |
NEW
|
258,740 | $69,011,133 | — | 13F Filing | 2026-06-30 | 2026-08-14 | ||
|
DXCM
DEXCOM INC
|
Healthcare | 6.80% | 6.15% |
#5
3
Prev: #8
|
5.2 |
—
|
122,321 | 17.5% |
P
S
|
820,479 | $55,259,261 | 2023 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
AXSM
AXSOME THERAPEU...
|
Healthcare | 6.60% | 1.47% |
#6
10
Prev: #16
|
5.6 |
—
|
157,192 | 253.1% |
P
S
|
219,308 | $53,680,019 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
JAZZ
JAZZ PHARMACEUT...
|
Healthcare | 6.57% | 4.21% |
#7
5
Prev: #12
|
5.1 |
—
|
63,057 | 39.7% |
P
S
|
221,720 | $53,427,868 | 2021 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ELVN
ENLIVEN THERAPE...
|
Healthcare | 5.41% | — |
#8
Prev: #—
|
5.7 |
—
|
866,716 | — |
NEW
|
866,716 | $43,985,837 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ARGX
ARGENX SE
|
Healthcare | 4.75% | 3.24% |
#9
4
Prev: #13
|
4.4 |
—
|
9,961 | 31.5% |
P
S
|
41,596 | $38,591,521 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 4.51% | 7.59% |
#10
3
Prev: #7
|
1.8 |
—
|
-35,015 | -33.9% |
P
S
|
68,273 | $36,659,187 | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 3.50% | — |
#11
Prev: #—
|
4.9 |
—
|
151,822 | — |
NEW
|
151,822 | $28,433,224 | 2022 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
UTHR
UNITED THERAPEU...
|
Healthcare | 3.13% | 5.86% |
#12
3
Prev: #9
|
1.3 |
—
|
-23,344 | -33.2% |
P
S
|
47,026 | $25,480,098 | 2021 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TEVA
TEVA PHARMACEUT...
|
Healthcare | 3.11% | 4.32% |
#13
2
Prev: #11
|
1.2 |
—
|
-274,173 | -26.9% |
P
S
|
746,835 | $25,302,770 | 2021 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TARS
TARSUS PHARMACE...
|
Healthcare | 2.54% | 2.49% |
#14
Prev: #14
|
3.5 |
—
|
75,752 | 30.0% |
P
S
|
328,340 | $20,665,720 | 2025 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ISRG
INTUITIVE SURGI...
|
Healthcare | 2.35% | 9.91% |
#15
13
Prev: #2
|
0.9 |
—
|
-105,267 | -68.7% |
P
S
|
47,983 | $19,081,879 | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
CYTK
CYTOKINETICS IN...
|
Healthcare | 2.03% | — |
#16
Prev: #—
|
4.3 |
—
|
194,000 | — |
NEW
|
194,000 | $16,526,860 | 2021 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DNTH
DIANTHUS THERAP...
|
Healthcare | 1.45% | 1.71% |
#17
2
Prev: #15
|
1.1 |
—
|
-24,831 | -17.1% |
P
S
|
120,712 | $11,767,006 | 2025 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
BBNX
BETA BIONICS IN...
|
Healthcare | 0.95% | — |
#18
Prev: #—
|
3.9 |
—
|
493,344 | — |
NEW
|
493,344 | $7,730,700 | 2026 Q2 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
DFTX
DEFINIUM THERAP...
|
Healthcare | 0.94% | 0.98% |
#19
2
Prev: #17
|
0.4 |
—
|
-206,592 | -55.9% |
P
S
|
162,996 | $7,667,332 | 2026 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
NUVL
NUVALENT INC
|
Healthcare | 0.00% | 4.44% |
Sold All 😨
(Was: #10) |
0.0 |
—
|
-308,506 | -100.0% |
CLOSED
|
— | $— | 2023 Q3 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 0.00% | 8.20% |
Sold All 😨
(Was: #4) |
0.0 |
—
|
-255,332 | -100.0% |
CLOSED
|
— | $— | 2022 Q4 | 13F Filing | 2026-06-30 | 2026-08-14 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.00% | 9.13% |
Sold All 😨
(Was: #3) |
0.0 |
—
|
-132,413 | -100.0% |
CLOSED
|
— | $— | 2023 Q1 | 13F Filing | 2026-06-30 | 2026-08-14 |
Showing 1-22 of 22 holdings